132 related articles for article (PubMed ID: 26261536)
41. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
[TBL] [Abstract][Full Text] [Related]
42. Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size.
Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):405-413. PubMed ID: 28986041
[TBL] [Abstract][Full Text] [Related]
43. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
44. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution.
Alijo Serrano F; Sánchez-Mora N; Angel Arranz J; Hernández C; Alvarez-Fernández E
Am J Clin Pathol; 2007 Nov; 128(5):733-9. PubMed ID: 17951193
[TBL] [Abstract][Full Text] [Related]
45. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.
Ritter JH; Dresler CM; Wick MR
Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697
[TBL] [Abstract][Full Text] [Related]
46. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
47. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
48. [Expression and clinical significance of LRP16 gene in human breast cancer].
Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH
Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279
[TBL] [Abstract][Full Text] [Related]
49. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
50. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
51. Combined large cell neuroendocrine carcinoma and spindle cell carcinoma of the lung.
Goto T; Maeshima A; Kato R
Jpn J Clin Oncol; 2011 Jun; 41(6):797-802. PubMed ID: 21415004
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous metastasis from pulmonary large cell neuroendocrine carcinoma in the scalp.
Ishida M; Iwai M; Kagotani A; Iwamoto N; Okabe H
Int J Clin Exp Pathol; 2014; 7(5):2701-6. PubMed ID: 24966991
[No Abstract] [Full Text] [Related]
53. Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer.
Lafuente-Sanchis A; Zúñiga Á; Estors M; Martínez-Hernández NJ; Cremades A; Cuenca M; Galbis JM
Clin Lung Cancer; 2017 Mar; 18(2):e109-e116. PubMed ID: 27816393
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
[TBL] [Abstract][Full Text] [Related]
55. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity.
Iyoda A; Hiroshima K; Moriya Y; Mizobuchi T; Otsuji M; Sekine Y; Shibuya K; Iizasa T; Saitoh Y; Fujisawa T
Ann Thorac Surg; 2004 Jun; 77(6):1891-5; discussion 1895. PubMed ID: 15172230
[TBL] [Abstract][Full Text] [Related]
56. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
57. S100A16 is a Prognostic Marker for Lung Adenocarcinomas.
Saito K; Kobayashi M; Nagashio R; Ryuge S; Katono K; Nakashima H; Tsuchiya B; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
Asian Pac J Cancer Prev; 2015; 16(16):7039-44. PubMed ID: 26514487
[TBL] [Abstract][Full Text] [Related]
58. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
[TBL] [Abstract][Full Text] [Related]
59. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases.
Takei H; Asamura H; Maeshima A; Suzuki K; Kondo H; Niki T; Yamada T; Tsuchiya R; Matsuno Y
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):285-92. PubMed ID: 12167788
[TBL] [Abstract][Full Text] [Related]
60. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
